Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Cash from Investing Activities

Arbutus Biopharma Cp Cash from Investing Activities Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Cash from Investing Activities from 2010 to 2018.
  • Arbutus Biopharma Cp Cash from Investing Activities for the quarter ending December 12, 2018 was $45m a 268.86% increase of 120m year over year
  • Arbutus Biopharma Cp Cash from Investing Activities for the last 12 months ending December 12, 2018 was $-4m a -1,632.59% increase of 67m year over year
  • Arbutus Biopharma Cp Annual Cash from Investing Activities for 2018 was $-4m a 778.05% decrease of -32m from 2017
  • Arbutus Biopharma Cp Annual Cash from Investing Activities for 2017 was $28m a 456.56% increase of 127m from 2016
  • Arbutus Biopharma Cp Annual Cash from Investing Activities for 2016 was $-99m a 107.75% decrease of -107m from 2015
Other Cash Flow Metrics:
  • Arbutus Biopharma Cp Cash Flow from Operations for the quarter ending December 12, 2018 was $-17m a -16.70% increase of 3m year over year
  • Arbutus Biopharma Cp Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-36m a 63.34% decrease of -23m year over year
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS Cash from Investing Activities Data

12/2018$45m
09/2018$24m
06/2018$15m
03/2018$-76m
12/2017$1m
09/2017$5m
06/2017$-1m
03/2017$23m
12/2016$1m
09/2016$-1m

Annual ABUS Cash from Investing Activities Data

2018$-4m
2017$28m
2016$-99m
2015$8m
2014$-43m
2013$-1m
2012$0m
2011$0m
2010$-1m
2009$4m